{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:20:38Z","timestamp":1759936838411},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Promethazine is an antihistamine agent used commonly for nausea and allergy. Along with its anticholinergic and antidopaminergic functions, promethazine is also used for psychiatric symptoms, such as troubling sleep, anxiety, and agitation. Previous studies have reported that promethazine may occasionally elicit acute dystonia in some individuals, especially for young children and pregnant women.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>The 68-year-old female patient was admitted to our hospital because of feeling anxious and intermittent palpitation for over 1 year. She developed acute orofacial dystonia following promethazine treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Her diagnoses was generalized anxiety disorder.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Discontinuation of the offending agent, promethazine, and injection of Botulinum toxin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The acute orofacial dystonia was finally alleviated by local injection of Botulinum toxin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Careful assessment of the risk of developing acute dystonia is also needed in old patients when initiating the promethazine treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000017675","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T19:22:49Z","timestamp":1571858569000},"page":"e17675","source":"Crossref","is-referenced-by-count":8,"title":["Acute onset of orofacial dystonia from promethazine treatment"],"prefix":"10.1097","volume":"98","author":[{"given":"Ruili","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Psychiatry, First Affiliated Hospital, Zhejiang University School of Medicine"},{"name":"The Key Laboratory of Mental Disorder's Management of Zhejiang Province"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbo","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, First Affiliated Hospital, Zhejiang University School of Medicine"},{"name":"The Key Laboratory of Mental Disorder's Management of Zhejiang Province"},{"name":"Brain Research Institute of Zhejiang University, Hangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinwen","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, First Affiliated Hospital, Zhejiang University School of Medicine"},{"name":"The Key Laboratory of Mental Disorder's Management of Zhejiang Province"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,10]]},"reference":[{"key":"R1-20240516","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/ajhp\/57.16.1499","article-title":"Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects","volume":"57","author":"Strenkoski-Nix","year":"2000","journal-title":"Am J Health Syst Pharm"},{"key":"R2-20240516","first-page":"391","article-title":"Dopamine D2 receptor binding sites for agonists. A tetrahedral model","volume":"28","author":"Seeman","year":"1985","journal-title":"Mol Pharmacol"},{"key":"R3-20240516","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/AOG.0b013e3181d99290","article-title":"Promethazine compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial","volume":"115","author":"Tan","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R4-20240516","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00006565-198706000-00007","article-title":"Promethazine-induced dystonic reaction","volume":"3","author":"DeGrandi","year":"1987","journal-title":"Pediatr Emerg Care"},{"key":"R5-20240516","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0361-9230(83)90190-9","article-title":"Case vignettes of movement disorders","volume":"11","author":"Yung","year":"1983","journal-title":"Brain Res Bull"},{"key":"R6-20240516","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/head.12712","article-title":"Movement disorders from the use of metoclopramide and other antiemetics in the treatment of migraine","volume":"56","author":"Wijemanne","year":"2016","journal-title":"Headache"},{"key":"R7-20240516","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archpsyc.1983.01790090075012","article-title":"Initial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromes","volume":"40","author":"Keepers","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"R8-20240516","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41467-017-00716-z","article-title":"Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors","volume":"8","author":"Sykes","year":"2017","journal-title":"Nat Commun"},{"key":"R9-20240516","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-207215","article-title":"Medication-induced acute dystonic reaction: the challenge of diagnosing movement disorders in the intensive care unit","author":"Digby","year":"2015","journal-title":"BMJ Case Rep"},{"key":"R10-20240516","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4088\/JCP.v59n0307","article-title":"Cocaine as a risk factor for neuroleptic-induced acute dystonia","volume":"59","author":"van Harten","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R11-20240516","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1056\/NEJM200506233522522","article-title":"Boxed warning added to promethazine labeling for pediatric use","volume":"352","author":"Starke","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T22:02:14Z","timestamp":1715896934000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017675"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":11,"journal-issue":{"issue":"43","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017675","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}